12.60BMarket Cap-28118P/E (TTM)
0.000High0.000Low0Volume0.000Open329.830Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)38.20MShares329.99052wk High10.05P/B11.98BFloat Cap158.37552wk Low--Dividend TTM36.32MShs Float329.990Historical High--Div YieldTTM0.00%Amplitude11.240Historical Low--Avg Price1Lot Size
Karuna Therapeutics Stock Forum
ColumnsDon't Just Focus on AI! Biotech Stocks Are Rallying
Big Pharma’s patent cliff issue
Big Pharma’s patent cliff issue getting mainstream media attention,
Top 20 biopharma have $180 bil in sales at risk from patent expirations by 2028 according to EY,
But that estimate could prove low compared to…👇
Bloomberg Intelligence business estimates 170 drugs w/ close to $400 bil in est global sales could lose patent excl by start of next decade,
Big Pharma wants to avoid stagnant rev g...
Why Is RayzeBio Stock Up 100% Today?
This is the second big buy in a week for Bristol Myers, which has a market cap of over $106 billion. Earlier it bought Karuna Therapeutics ($Karuna Therapeutics(KRTX.US)$ ), for $14 billion. Karuna makes drugs targeting schizophrenia and Alzheimer’s.
RayzeBio has not yet gotten any drugs approved. It has one drug, RYZ101, in a Stage 3 clinical trial, for treating endocrine tumors. The drug als...
The best to invest ASAP
$Rocket Lab(RKLB.US)$
No comment yet